Annual report [Section 13 and 15(d), not S-K Item 405]

DEBT - Promissory Notes, Kind Therapeutics USA (Details)

v3.25.0.1
DEBT - Promissory Notes, Kind Therapeutics USA (Details) - USD ($)
12 Months Ended
Jan. 24, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]        
Cash paid for interest   $ 6,689,000 $ 5,654,000  
Kind Acquisition | Kind Notes | Promissory Notes        
Debt Instrument [Line Items]        
Term of promissory note       4 years
Mortgage value       $ 6,500,000
Stated interest rate       6.00%
Payment on mortgage $ 5,400,000      
Cash paid for interest $ 420,000